UNITED STATES

0001551163-16-000549.txt : 20161121 0001551163-16-000549.hdr.sgml : 20161121 20161121143754 ACCESSION NUMBER: 0001551163-16-000549 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 30 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161121 DATE AS OF CHANGE: 20161121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROTECT PHARMACEUTICAL Corp CENTRAL INDEX KEY: 0001493526 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271877179 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-54001 FILM NUMBER: 162010039 BUSINESS ADDRESS: STREET 1: 2681 EAST PARLEYS WAY STREET 2: SUITE 204 CITY: SALT LAKE CITY STATE: UT ZIP: 84109 BUSINESS PHONE: 8013223401 MAIL ADDRESS: STREET 1: 2681 EAST PARLEYS WAY STREET 2: SUITE 204 CITY: SALT LAKE CITY STATE: UT ZIP: 84109 10-Q 1 f10qseptember302016edgarjiev.htm UNITED STATES

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the Quarter Ended September 30, 2016

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the transition period from _____ to ______

Commission File Number 000-54001

PROTECT PHARMACEUTICAL CORPORATION

(Exact name of registrant as specified in its charter)

Nevada

27-1877179

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer Identification No.)

95 Merrick Way, Third Floor, Coral Gables, Florida 33143

(Address of principal executive offices)

(954) 292-0033

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [ ] No [X ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company


Large accelerated filer [ ]		Accelerated filer [ ]
Non-accelerated filer [ ]		Smaller reporting company [X]
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [ X] No [ ]

APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date.


Class	Outstanding as of November 21, 2016
Common Stock, $0.005 par value	1,111,460


PART I.	FINANCIAL INFORMATION

	ITEM 1.	Financial Statements
		Condensed balance sheets as of September 30, 2016 (unaudited) and December 31, 2015	4
		Condensed statements of operations for the three and nine months ended September 30, 2016 and 2015 (unaudited)	5
		Condensed statements of cash flows for the nine months ended September 30, 2016 and 2015 (unaudited)	7
		Notes to condensed financial statements (unaudited)	8-27
	ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	28-38
	ITEM 3.	Quantitative and Qualitative Disclosures about Market Risk	38
	ITEM 4.	Controls and Procedures	38

PART II.	OTHER INFORMATION

	ITEM 1.	Legal Proceedings	39
	ITEM 1A.	Risk Factors	39
	ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	39
	ITEM 3.	Defaults Upon Senior Securities	39
	ITEM 4.	Mine Safety Disclosures	39
	ITEM 5.	Other Information	39
	ITEM 6.	Exhibits	40
	SIGNATURES		45
EX 31.01	Management Certification
EX 32.01	Sarbanes-Oxley Act

FORWARD-LOOKING STATEMENTS

This Quarterly Report contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 ("PSLRA") regarding management’s plans and objectives for future operations including plans and objectives relating to our planned marketing efforts and future economic performance. The forward-looking statements and associated risks set forth in this Report include or relate to, among other things, (a) our growth strategies, (b) anticipated trends in the mining industry, (c) currency fluctuations, (d) our ability to obtain and retain sufficient capital for future operations, and (e) our anticipated needs for working capital. These statements may be found under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Description of Business,”. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including, without limitation, the risks outlined under “Risk Factors”. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this report will in fact occur.

The forward-looking statements herein are based on current expectations that involve a number of risks and uncertainties. Such forward-looking statements are based on assumptions described herein. The assumptions are based on judgments with respect to, among other things, future economic, competitive and market conditions, and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control. Accordingly, although we believe that the assumptions underlying the forward-looking statements are reasonable, any such assumption could prove to be inaccurate and therefore there can be no assurance that the results contemplated in forward-looking statements will be realized. In addition, there are a number of other risks inherent in our business and operations, which could cause our operating results to vary markedly, and adversely from prior results or the results contemplated by the forward-looking statements. Management decisions, including budgeting, are subjective in many respects and periodic revisions must be made to reflect actual conditions and business developments, the impact of which may cause us to alter marketing, capital investment and other expenditures, which may also materially adversely affect our results of operations. In light of significant uncertainties inherent in the forward-looking information included in the report statement, the inclusion of such information should not be regarded as a representation by us or any other person that our objectives or plans will be achieved.

Any statement in this report that is not a statement of an historical fact constitutes a “forward-looking statement”. Further, when we use the words “may”, “expect”, “anticipate”, “plan”, “believe”, “seek”, “estimate”, “internal”, and similar words, we intend to identify statements and expressions that may be forward- looking statements. We believe it is important to communicate certain of our expectations to our investors. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions that could cause our future results to differ materially from those expressed in any forward-looking statements. Many factors are beyond our ability to control or predict. You are accordingly cautioned not to place undue reliance on such forward-looking statements. Important factors that may cause our actual results to differ from such forward-looking statements include, but are not limited to, the risks outlined under “Risk Factors” herein. The reader is cautioned that our Company does not have a policy of updating or revising forward-looking statements and thus the reader should not assume that silence by management of our Company over time means that actual events are bearing out as estimated in such forward-looking statements.

PART I — FINANCIAL INFORMATION


Item 1.	Financial Statements

The accompanying unaudited balance sheet of Protect Pharmaceutical Corporation at September 30, 2016 and related unaudited statements of operations and cash flows for the three and nine months ended September 30, 2016 and 2015, have been prepared by management in conformity with United States generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature. We suggest that these financial statements be read in conjunction with the audited financial statements and notes thereto included in the company’s December 31, 2015 Form 10-K Annual Report. Operating results for the period ended September 30, 2016, are not necessarily indicative of the results that can be expected for the fiscal year ending December 31, 2016 or any other subsequent period.


PROTECT PHARMACEUTICAL CORPORATION
Balance Sheets

ASSETS

			September 30,		December 31,
			2016		2015
			(Unaudited)
CURRENT ASSETS

	Cash		$	45	$	7

		Total Current Assets		45		7

		TOTAL ASSETS	$	45	$	7

LIABILITIES AND STOCKHOLDERS' DEFICIT

CURRENT LIABILITIES

	Accounts payable and accrued expenses		$	33,184	$	69,656
	Related party payables			-		30,798

		Total Current Liabilities		33,184		100,454

		TOTAL LIABILITIES		33,184		100,454

STOCKHOLDERS' DEFICIT

	Preferred stock; 10,000,000 shares authorized,
	at $0.001 par value, no shares issued or outstanding			-		-
	Common stock; 100,000,000 shares authorized,
	at $0.005 par value, 1,111,460 and 1,111,460
	shares issued and outstanding, respectively			5,557		5,557
	Additional paid-in capital			9,334,258		9,244,288
	Accumulated Deficit			(9,372,954)		(9,350,292)

		Total Stockholders' Deficit		(33,139)		(100,447)

		TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	45	$	7

The accompanying notes are an integral part of these condensed financial statements.


PROTECT PHARMACEUTICAL CORPORATION
Statements of Operations
(Unaudited)

		For the Three Months Ended				For the Nine Months Ended
		September 30,				September 30,
		2016		2015		2016		2015

REVENUES		$	-	$	-	$	-	$	-

EXPENSES

	Professional Fees		7,290		7,305		18,225		17,094
	Executive compensation		1,150		1,500		4,150		4,500
	General and administrative		92		1,650		287		1,861

LOSS FROM OPERATIONS			(8,532)		(10,455)		(22,662)		(23,455)

OTHER EXPENSES

	Loss on settlement of debt		-		(605,437)		-		(605,437)

LOSS FROM OPERATIONS			(8,532)		(615,892)		(22,662)		(628,892)

	Income Taxes		-		-		-		-

NET LOSS		$	(8,532)	$	(615,892)	$	(22,662)	$	(628,892)

BASIC AND DILUTED LOSS PER SHARE OF
	COMMON STOCK	$	(0.01)	$	(0.55)	$	(0.02)	$	(0.57)

WEIGHTED AVERAGE NUMBER OF
SHARES OUTSTANDING			1,111,460		1,111,460		1,111,460		1,111,460

The accompanying notes are an integral part of these condensed financial statements.


PROTECT PHARMACEUTICAL CORPORATION
Statements of Cash Flows
(Unaudited)

			For the Nine Months Ended
			September 30,
			2016		2015

OPERATING ACTIVITIES

	Net loss		$	(22,662)	$	(628,892)
Adjustments to reconcile net loss
to cash flows from operating activities
	Services contributed by an officer			4,150		4,500
	Loss on settlement of debt			-		605,437
Changes in operating assets and liabilities
	Accounts payable			4,399		5,847
	Accounts payable - related parties			-		(2,380)
		Net Cash Provided by (Used in)
		Operating Activities		(14,113)		(15,488)

INVESTING ACTIVITIES				-		-

FINANCING ACTIVITIES

	Proceeds from notes payable - related parties			14,151		15,150

Net cash provided by financing activities				14,151		15,150

NET CHANGE IN CASH				38		(338)

CASH AT BEGINNING OF PERIOD				7		502

CASH AT END OF PERIOD			$	45	$	164

SUPPLEMENTAL CASH FLOW INFORMATION:
	NON-CASH FINANCING ACTIVITIES:

		Common shares issued for rounding
		pursuant to reverse stock-split	$	-	$	110
		Common stock issued for
		Settlement of debt	$	-	$	650,000
		Accounts payable paid by shareholder	$	40,871		-
		Forgiveness of related-party notes payable	$	44,949		-



The accompanying notes are an integral part of these condensed financial statements.

PROTECT PHARMACEUTICAL CORPORATION

Notes to Condensed Financial Statements

September 30, 2016

(Unaudited)

NOTE 1 - CONDENSED FINANCIAL STATEMENTS

The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at September 30, 2016, and for all periods presented herein, have been made.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company's December 31, 2015 audited financial statements. The results of operations for the periods ended September 30, 2016 and 2015 are not necessarily indicative of the operating results for the full years.

NOTE 2 - GOING CONCERN

The Company’s financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company does not have significant cash or other material assets, nor does it have an established source of revenues sufficient to cover its operating costs and to allow it to continue as a going concern. It is the intent of the Company to seek a merger with an existing, operating company. In the interim, shareholders of the Company have committed to meeting its minimal operating expenses

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Basic Loss per Common Share

Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of September 30, 2016 and 2015.

Recent Accounting Pronouncements

Management has considered all other recent accounting pronouncements issued since the last audit of the Company’s financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.

NOTE 4 – RELATED-PARTY TRANSACTIONS

The Company has recorded advances from related parties and expenses paid by related parties on behalf of the Company as related party payables. As of September 30, 2016 and December 31, 2015, respectively, the related party payable outstanding balance totaled $0 and $30,798, respectively. These payables are non-interest bearing, unsecured, and are due on demand.

During the nine months ended September 30, 2016, $40,871 of the accounts payable of the Company was paid by a significant shareholder. Also during the nine months ended September 30, 2016, $44,949 in related-party notes payable were forgiven by the Company’s note holders.

Contributed Capital

During the nine months ended September 30, 2016 and 2015, a related-party has contributed various administrative services to the Company. These services have been valued at $4,150 and $4,500, respectively, for the nine month periods then ended.

NOTE 5 – STOCKHOLDERS EQUITY

NOTE 6 – CHANGE OF CONTROL

As reported on Schedule 14f, filed with the Securities and Exchange Commission on September 9, 2016, effective September 9, 2016, Deworth Williams, the principal stockholder of the Company (“Williams”), entered into a Stock Purchase Agreement (the “Agreement”), as amended (the “Amended Agreement”), dated, August 30, 2016, with Taylor Group Holdings, LLC (the “Buyer”), a Florida Limited Liability Company, pursuant to which, among other things, Williams agreed to sell to the Buyer, and the Buyer agreed to purchase from Williams, a total of 937,063 shares of Common Stock owned of record and beneficially by Williams (the“Purchased Shares”). The Purchased Shares represented approximately 84.3% of the Company’s issued and outstanding shares of Common Stock as of the Record Date. In connection with the transactions contemplated by the Agreement, the Board appointed Una Taylor and Theodore Faison to fill vacancies on the Company’s Board of Directors, effective September 19, 2016.

On September 7^th2016, an option agreement was entered into by the Company and Alex Woodruff. The agreement gives Mr. Woodruff the option to purchase all of the mining claims of the Corporation. It became efffective on November 8, 2016, and is exercisable until December 8, 2016.The claims may be purchased at $25 per claim.

NOTE 7 – SUBSEQUENT EVENTS

In accordance with ASC 855-10, Company management reviewed all material events through the date of this report and determined that there are no additional material subsequent events to report.

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

The Following information should be read in conjunction with the consolidated financial statements and notes thereto appearing elsewhere in this Form 10-Q.

Forward-Looking and Cautionary Statements

Unless otherwise indicated, references in this Quarterly Report on Form 10-Q to “we,” “us,” and “our” are to the Company, unless the context requires otherwise. The following discussion and analysis by our management of our financial condition and results of operations should be read in conjunction with our unaudited condensed interim financial statements and the accompanying related notes included in this quarterly report and our audited financial statements and related notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2015 filed with the Securities and Exchange Commission.

Cautionary Statement Regarding Forward-Looking Statements

This report may contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, and we intend that such forward-looking statements be subject to the safe harbors created thereby. These forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Any such forward-looking statements would be contained principally in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors.” Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, financing plans, competitive position, industry environment, potential growth opportunities and the effects of regulation. Forward-looking statements include all statements that are not historical facts and can be identified by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “hopes,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” or similar expressions.

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We discuss many of these risks in greater detail in “Risk Factors.” Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this report. You should read this report and the documents that we reference in this report and have filed as exhibits to the report completely and with the understanding that our actual future results may be materially different from what we expect. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Additional information concerning these and other risks and uncertainties is contained in our filings with the Securities and Exchange Commission, including the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2015.

Unless otherwise indicated or the context otherwise requires, all references in this Form 10-Q to “we,” “us,” “our,” “our company,” “Protect” refer to Protect Pharmaceutical Corporation.

Our Ability to Continue as a Going Concern

Our independent registered public accounting firm has issued its report dated April 13, 2016, in connection with the audit of our annual financial statements as of December 31, 2015, that included an explanatory paragraph describing the existence of conditions that raise substantial doubt about our ability to continue as a going concern and Note 2 to the unaudited financial statements for the period ended September 30, 2016 also describes the existence of conditions that raise substantial doubt about our ability to continue as a going concern.

Results of Operations

Three and nine months Ended September 30, 2016 and 2015

We did not realize revenues for the three-month and nine month periods ended September 30, 2016 and 2015. For the three months ended September 30, 2016 (“third quarter”), total operating expenses were $8,532, consisting of $7,290 in professional fees, $1,150 in executive compensation and $92 in general and administrative expenses. Total operating expenses for the comparable third quarter of 2015 were $10,455, consisting of $7,305 in professional fees, $1,500 in executive compensation and $1,650 in general and administrative expenses. The decrease in operating expenses during the third quarter of 2016 was due primarily to decreased professional fees, due to decreased costs related to ongoing reporting obligations with the Securities and Exchange Commission. The net loss for the third quarter of 2016 was $8,532 ($0.01 per share), compared to net loss of $615,892 ($0.55 per share) for the third quarter of 2015.

For the nine months ended September 30, 2016, total operating expenses were $22,662, consisting of $18,225 in professional fees, $4,150 in executive compensation and $287 in general and administrative expenses. Total operating expenses for the comparable first nine months of 2015 were $23,455, consisting of $17,094 in professional fees, $4,150 in executive compensation and $1,861 in general and administrative expenses. The decrease in operating expenses during the first nine months of 2016 was due primarily to decrease in professional fees, related to decreased costs of ongoing reporting obligations with the Securities and Exchange Commission. The net loss for the first nine months of 2016 was $22,662 ($0.02 per share), compared to net loss of $628,892 ($0.57 per share) for the first nine months of 2015.

Liquidity and Capital Resources

Total assets at September 30, 2016 were $45 in cash, compared to $7 in cash at December 31, 2015. Total liabilities at September 30, 2016 were $33,184, consisting of $33,184 in accounts payable and accrued expenses, and $0 in related-party payables. At December 31, 2015, total liabilities were $100,454, consisting of $69,656 in accounts payable and accrued expenses, and $30,798 in related-party payables.

Because we currently have no revenues and limited available cash, for the immediate future we believe we will have to rely on potential advances from stockholders to continue to implement our business activities. There is no assurance that our stockholders will continue indefinitely to provide additional funds or pay our expenses. It is likely the only other source of funding future operations will be through the private sale of our securities, either equity or debt.

At September 30, 2016, we had stockholders’ deficit of $33,139 compared to stockholders’ deficit of $100,447 at December 31, 2015. The decreased deficit during the first nine months of 2016 is primarily due to the net loss of $22,662 and the decrease in accounts payable from $69,656 to $33,184, and the decrease in related party payables from $30,798 to $0 during the first nine months of 2016.

Plan of Operation

Following the sale of patents, patent applications and technologies in 2011, we have endeavored to explore possible plans for the remaining patents and new generation drug delivery technologies acquired in 2010. However, without adequate personnel with the requisite scientific expertise, we found it difficult to further develop the technologies and endeavored to explore alternative business ventures. Following the acquisition of certain mining and mineral claims and leases in September 2014, we had directed our focus on the initial exploration of the acquired properties to determine whether there is commercial potential. We have subsequently abandoned our business plan.

We were classified or considered an exploration stage mining company, which is defined as a company engaged in the search for mineral deposits or reserves of precious and base metal targets, which are not in either the development or production stage. We had no known mineral reserves on our properties and our proposed preliminary studies of the claims is intended to be exploratory in nature.

As reported on Schedule 14f, filed with the Securities and Exchange Commission on September 9, 2016, effective September 9, 2016, Deworth Williams, the principal stockholder of the Company (“Williams”), entered into a Stock Purchase Agreement (the “Agreement”), as amended (the “Amended Agreement”), dated, August 30, 2016, with Taylor Group Holdings, LLC (the “Buyer”), a Florida Limited Liability Company, pursuant to which, among other things, Williams agreed to sell to the Buyer, and the Buyer agreed to purchase from Williams, a total of 937,063 shares of Common Stock owned of record and beneficially by Williams (the“Purchased Shares”). The Purchased Shares represented approximately 84.3% of the Company’s issued and outstanding shares of Common Stock as of the Record Date. In connection with the transactions contemplated by the Agreement, the Board appointed Una Taylor and Theodore Faison to fill vacancies on the Company’s Board of Directors, effective September 19, 2016.

Our new management intends to acquire DreamFu Ventures LLC a Florida LLC in a transaction that will result in the DreamFu entity becoming the operating entity in our company (“Merger”) and that will also result in us acquiring 100% of the issued and outstanding equity of DreamFu Ventures LLC, a related party with common management. While no assurances can be provided as to the final consummation of this transaction, it is intended that going-forward DreamFu Ventures LLC shall produce operations and cash flow which shall sustain the enterprise. Prior to the Merger, commencing in the fourth quarter of 2016, the DreamFu business will be incorporated into the business of our Company.

DreamFu Ventures LLC intends to create an entire ecosystem whose mission is to transform the startup entrepreneurial landscape to be inclusive, diversified and successful! We intend to create a gamified, online platform that encompasses the entire startup journey, allowing us to work with entrepreneurs at any stage - from ideation and getting started to funding successful exits. DreamFu Ventures LLC is currently operated by related parties, specifically Una Taylor. We intend to create a network of mentors and angels investors to help shape ideas, grow entrepreneurs, and invest in startup companies from the ground up. DreamFu Ventures is a dream trainer, builder and investor - the only start to end ecosystem available to all startup entrepreneurs.

Because we currently have limited cash, it may be necessary for officers, directors or stockholders to advance funds and we will most likely accrue expenses until a funding can be accomplished. Management intends to hold expenses to a minimum and to obtain services on a contingency basis when possible. Further, we expect directors to defer any compensation until such time as we have sufficient funds. We have not yet entered into any arrangements or definitive agreements to use outside advisors or consultants or to raise any capital.

We are currently exploring possible funding sources, but we have not entered into any arrangements or agreements for funding as of this time. If we are unable to raise the necessary funding, our expansion plans will be delayed indefinitely. There can be no assurance that we will be able to raise the funds necessary to carry out our business plan on terms favorable to the company, or at all.

Off-balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not required under Regulation S-K for “smaller reporting companies.”

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures.

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms. Disclosure and control procedures are also designed to ensure that such information is accumulated and communicated to management, including the chief executive officer and principal accounting officer, to allow timely decisions regarding required disclosures.

As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of management, including our chief executive officer and principal accounting officer, of the effectiveness of the design and operation of our disclosure controls and procedures. In designing and evaluating the disclosure controls and procedures, management recognizes that there are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their desired control objectives. Additionally, in evaluating and implementing possible controls and procedures, management is required to apply its reasonable judgment. Based on the evaluation described above, management, including our principal executive officer and principal accounting officer, has concluded that, as of September 30, 2016, our disclosure controls and procedures were not effective.

Changes in Internal Control Over Financial Reporting.

Management has evaluated whether any change in our internal control over financial reporting occurred during the second quarter of fiscal 2016. Based on its evaluation, management, including the chief executive officer and principal accounting officer, has concluded that there has been no change in our internal control over financial reporting during the second quarter of fiscal 2016 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

There are no material pending legal proceedings to which we are a party or to which any of our property is subject and, to the best of our knowledge, no such actions against us are contemplated or threatened.

Item 1A. Risk Factors

Not required under Regulation S-K for “smaller reporting companies.”

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

There were no defaults upon senior securities during the period ended September 30, 2016

Item 4.

Mine Safety Disclosures

This Item is not applicable.

Item 5. Other Information

On September 8, 2016, Geoffrey Williams reported his resignation as an officer and Director of the Company. On November 14, 2016, Una Taylor, the current President and a member of the Board of Directors, was appointed as the Chief Executive Officer and Chief Financial Officer (Principal Accounting Officer).

None.

Item 6. Exhibits


Exhibit No.		Exhibit Name
2.1*		Patent Acquisition Agreement
2.2*		Patent Portfolio
3.1*		Articles of Incorporation
3.2*		Certificate of Amendment - Capitalization Change
3.3*		Certificate of Amendment - Name Change 2006
3.4*		Certificate of Amendment - Name Change 2010
3.5*		By-Laws
4.1*		Instrument defining rights of holders – Specimen Stock Certificate
10.1*		Employment Agreement – Ramesha Sesha
10.2**		Employment Agreement – William D. Abajian
10.3***		Patent Purchase Agreement with Grünenthal GmbH
14.1**** 31.1		Financial Code of Ethics Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2		Certification of Principal Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2		Certification of Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



	*	Previously filed as exhibit to Form 10 filed June 8, 2010.
	**	Previously filed as exhibit to Amendment No.1 Form 10 filed July 21, 2010.



	***	Previously files as exhibit to Form 8-K filed on February 4, 2011.


*** *	Previously files as exhibit to Form 8-K filed on September 20, 2016.


101 INS	XBRL Instance Document
101 SCH	XBRL Taxonomy Extension Schema Document
101 CAL	XBRL Taxonomy Calculation Linkbase Document
101 DEF	XBRL Taxonomy Extension Definition Linkbase Document
101 LAB	XBRL Taxonomy Labels Linkbase Document
101 PRE	XBRL Taxonomy Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	Protect Pharmaceutical Corporation

Date: November 21, 2016	By:	/S/ UNA TAYLOR
		*Una Taylor*
		C.E.O. and Director Principal Accounting Officer

EX-31 2 exhibit311.htm Converted by EDGARwiz

Exhibit 31.1

CERTIFICATION PURSUANT TO
RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Geoff Williams, certify that:

I have reviewed this quarterly report on Form 10-Q of Protect Pharmaceutical Corporation.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 14, 2016


By:	/s/ Geoff Williams
	Geoff Williams
	Chief Executive Officer
	(principal executive officer)

EX-31 3 exhibit312.htm Converted by EDGARwiz

Exhibit 31.2

CERTIFICATION PURSUANT TO
RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Geoff Williams, certify that:

I have reviewed this quarterly report on Form 10-Q of Protect Pharmaceutical Corporation.;

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 14, 2016


By:	/s/ Geoff Williams
	Geoff Williams
	Chief Financial Officer
	(principal accounting officer)

EX-32 4 exhibit321.htm Converted by EDGARwiz

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Protect Pharmaceutical Corporation. (the "Company") for the period ended September 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Geoff Williams, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: November 14, 2016


By:	/s/ Geoff Williams
	Geoff Williams
	Chief Executive Officer
	(principal executive officer)

EX-32 5 exhibit322.htm Converted by EDGARwiz

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Protect Pharmaceutical Corporation. (the "Company") for the period ended September 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Geoff Williams, Chief Financial Officer (Principal Accounting Officer) of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: November 14, 2016


By:	/s/ Geoff Williams
	Geoff Williams
	Chief Financial Officer
	(principal accounting officer)

EX-101.INS 6 prtt-20160930.xml

880

69656

30798

880

100454

880

100454

5557

9365192

9244288

-9371584

-9350292

-835

-100447

10-Q 2016-09-30 false PROTECT PHARMACEUTICAL CORP 0001493526 prtt --12-31 1111460 1111460 Smaller Reporting Company No No No 2016 Q3

5570

7305

16505

17094

1500

4500

1650

287

1861

-7161

-10455

-21292

-23455

-605437

-7161

-615892

-21292

-628892

-7161

-615892

-21292

-628892

-0.01

-0.55

-0.02

-0.57

1111460

-21292

-628892

4500

116404

605437

-68776

5847

-30798

-2380

-15488

15150

-338

502

164

110

650000

NOTE 1 - CONDENSED FINANCIAL STATEMENTS   The accompanying financial statements have been prepared by the Company without audit.  In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows at September 30, 2016, and for all periods presented herein, have been made.   Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.  It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company's December 31, 2015 audited financial statements.  The results of operations for the periods ended September 30, 2016 and 2015 are not necessarily indicative of the operating results for the full years.

NOTE 3 SIGNIFICANT ACCOUNTING POLICIES <p style='margin-top:0in;margin-right:0in;margin-bottom:10.0pt;margin-left:0in;line-height:115%;margin-top:0in;margin-right:-27.0pt;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify'>  Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. Basic (Loss) per Common Share Basic loss per share is calculated by dividing the Companys net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Companys net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of September 30, 2016 and 2015. Recent Accounting Pronouncements Management has considered all other recent accounting pronouncements issued since the last audit of the Companys financial statements. The Companys management believes that these recent pronouncements will not have a material effect on the Companys financial statements.

<p style='margin-top:0in;margin-right:0in;margin-bottom:10.0pt;margin-left:0in;line-height:115%;margin-top:0in;margin-right:-.5in;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify'>NOTE 4 RELATED-PARTY TRANSACTIONS <p style='margin-top:0in;margin-right:0in;margin-bottom:10.0pt;margin-left:0in;line-height:115%;margin-top:0in;margin-right:-.5in;margin-bottom:0in;margin-left:0in;margin-bottom:.0001pt;text-align:justify'>  The Company has recorded advances from related parties and expenses paid by related parties on behalf of the Company as related party payables. As of September 30, 2016 and December 31, 2015, respectively, the related party payable outstanding balance totaled $0 and $30,798, respectively. These payables are non-interest bearing, unsecured, and are due on demand.   Contributed Capital During the nine months ended September 30, 2016 and 2015, a related-party has contributed various administrative services to the Company. These services have been valued at $3,000 for the nine month periods then ended.

NOTE 5 STOCKHOLDERS EQUITY   On September 19, 2014, the Company issued 26,000 shares of common stock to Blue Cap Development Corp. in exchange for certain mining and/or mineral claims and/or leases located in New Mexico. Two principals of Blue Cap, Edward F. Cowle and H. Deworth Williams, are principal stockholders of the Company.   On November 4, 2014, the Company effected a reverse stock split of its issued and outstanding shares of common stock on a one (1) share for one thousand (1,000) shares basis. As per the terms of the reverse stock split, any fractional share amount resulting from the split was automatically rounded up to the next higher whole share amount, with the provision that no individual stockholders holdings would be reduced below 100 shares. Additional shares to restore each such affected stockholders holdings to 100 shares were issued, with certain shares issued during the 2014 calendar year, and the remainder issued during the nine months ended September 30, 2015.  The par value of the common stock remains at $0.005 per share. As a result of the reverse stock split and the rounding up of odd lots to 100 shares, at September 30, 2015, there were 1,111,460 shares certificated and outstanding.

NOTE 6 SUBSEQUENT EVENTS In accordance with ASC 855-10, Company management reviewed all material events through the date of this report and determined that there are no additional material subsequent events to report. <table border="0" cellspacing="0" cellpadding="0" width="100%" style='width:100.0%;margin-left:.1pt'> <tr style='height:3.4pt'> <td width="90" valign="top" style='width:.75in;padding:0;height:3.4pt'></td></tr></table>

Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

Basic (Loss) per Common Share Basic loss per share is calculated by dividing the Companys net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Companys net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of September 30, 2016 and 2015.

Contributed Capital During the nine months ended September 30, 2016 and 2015, a related-party has contributed various administrative services to the Company. These services have been valued at $3,000 for the nine month periods then ended.

0001493526 2016-01-01 2016-09-30 0001493526 2016-09-30 0001493526 2016-06-30 0001493526 2015-12-31 0001493526 2016-07-01 2016-09-30 0001493526 2015-07-01 2015-09-30 0001493526 2015-01-01 2015-09-30 0001493526 2014-12-31 0001493526 2015-09-30 iso4217:USD shares iso4217:USD shares EX-101.SCH 7 prtt-20160930.xsd 000130 - Disclosure - Note 3 - Significant Accounting Policies: Recent Accounting Pronouncements (Policies) link:presentationLink link:definitionLink link:calculationLink 000090 - Disclosure - Note 5 - Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 000110 - Disclosure - Note 3 - Significant Accounting Policies: Use of Estimates (Policies) link:presentationLink link:definitionLink link:calculationLink 000080 - Disclosure - Note 4 - Related-party Transactions link:presentationLink link:definitionLink link:calculationLink 000060 - Disclosure - Note 2 - Going Concern link:presentationLink link:definitionLink link:calculationLink 000020 - Statement - Balance Sheets link:presentationLink link:definitionLink link:calculationLink 000140 - Disclosure - Note 4 - Related-party Transactions: Contributed Capital (Policies) link:presentationLink link:definitionLink link:calculationLink 000050 - Disclosure - Note 1 - Condensed Financial Statements link:presentationLink link:definitionLink link:calculationLink 000040 - Statement - Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 000120 - Disclosure - Note 3 - Significant Accounting Policies: Basic (loss) Per Common Share (Policies) link:presentationLink link:definitionLink link:calculationLink 000070 - Disclosure - Note 3 - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 000030 - Statement - Statements of Operations link:presentationLink link:definitionLink link:calculationLink 000100 - Disclosure - Note 6 - Subsequent Events link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 prtt-20160930_cal.xml EX-101.DEF 9 prtt-20160930_def.xml EX-101.LAB 10 prtt-20160930_lab.xml REVENUES Total Stockholders' Deficit Total Stockholders' Deficit Trading Symbol Contributed Capital Use of Estimates Proceeds from notes payable - related parties Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Operating Activities Accounts payable BASIC AND DILUTED LOSS PER SHARE OF COMMON STOCK Preferred stock; 10,000,000 shares authorized,at $0.001 par value, no shares issued or outstanding Amendment Flag SUPPLEMENTAL CASH FLOW INFORMATION: Changes in operating assets and liabilities TOTAL ASSETS TOTAL ASSETS Basic (loss) Per Common Share Notes Common stock; 100,000,000 shares authorized,at $0.005 par value, 111,460 and 89,459shares issued and outstanding, respectively Total Current Assets Total Current Assets Entity Common Stock, Shares Outstanding Recent Accounting Pronouncements OPERATING ACTIVITIES LOSS FROM OPERATIONS Deficit accumulated during the development stage Additional paid-in capital Document and Entity Information: Note 3 - Significant Accounting Policies NON-CASH FINANCING ACTIVITIES: NET CHANGE IN CASH NET CHANGE IN CASH REVENUES {1} REVENUES CURRENT LIABILITIES FINANCING ACTIVITIES Executive compensation EXPENSES Document Period End Date Note 4 - Related-party Transactions Common stock issued for Settlement of debt CASH AT BEGINNING OF PERIOD CASH AT BEGINNING OF PERIOD CASH AT END OF PERIOD Services contributed by an officer WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING NET INCOME LOSS NET INCOME LOSS LOSS BEFORE DISCONTINUED OPERATIONS Professional Fees Expenses paid on behalf of the Company Adjustments to reconcile net loss to cash flows from operating activities LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT ASSETS Entity Well-known Seasoned Issuer Note 6 - Subsequent Events Note 5 - Stockholders' Equity General and administrative Total Current Liabilities Total Current Liabilities ASSETS Document Fiscal Year Focus Change in loss on settlement of debt TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT Entity Current Reporting Status Current Fiscal Year End Date Entity Registrant Name Note 1 - Condensed Financial Statements Common shares issued for rounding pursuant to reverse stock-split Related party payables TOTAL LIABILITIES TOTAL LIABILITIES Cash Profit (loss) Document Fiscal Period Focus Note 2 - Going Concern OTHER EXPENSES STOCKHOLDERS' DEFICIT Entity Voluntary Filers Entity Central Index Key Document Type Policies INVESTING ACTIVITIES Accounts payable - related parties Loss on settlement of debt Accounts payable and accrued expenses Entity Filer Category Entity Public Float EX-101.PRE 11 prtt-20160930_pre.xml XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - USD ($)	9 Months Ended
Document and Entity Information - USD ($)	Sep. 30, 2016	Jun. 30, 2016
Document and Entity Information:
Entity Registrant Name	PROTECT PHARMACEUTICAL CORP
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Trading Symbol	prtt
Amendment Flag	false
Entity Central Index Key	0001493526
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding	1,111,460
Entity Public Float		$ 1,111,460
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	No
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q3

XML 13 R2.htm IDEA: XBRL DOCUMENT

Balance Sheets - USD ($)	Sep. 30, 2016	Dec. 31, 2015
CURRENT ASSETS
Cash	$ 45	$ 7
Total Current Assets	45	7
TOTAL ASSETS	45	7
CURRENT LIABILITIES
Accounts payable and accrued expenses	880	69,656
Related party payables		30,798
Total Current Liabilities	880	100,454
TOTAL LIABILITIES	880	100,454
STOCKHOLDERS' DEFICIT
Common stock; 100,000,000 shares authorized,at $0.005 par value, 111,460 and 89,459shares issued and outstanding, respectively	5,557	5,557
Additional paid-in capital	9,365,192	9,244,288
Deficit accumulated during the development stage	(9,371,584)	(9,350,292)
Total Stockholders' Deficit	(835)	(100,447)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 45	$ 7

XML 14 R3.htm IDEA: XBRL DOCUMENT

Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
Statements of Operations - USD ($)	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
EXPENSES
Professional Fees	$ 5,570	$ 7,305	$ 16,505	$ 17,094
Executive compensation	1,500	1,500	4,500	4,500
General and administrative	91	1,650	287	1,861
LOSS FROM OPERATIONS	(7,161)	(10,455)	(21,292)	(23,455)
OTHER EXPENSES
Loss on settlement of debt		(605,437)		(605,437)
LOSS BEFORE DISCONTINUED OPERATIONS	(7,161)	(615,892)	(21,292)	(628,892)
NET INCOME LOSS	$ (7,161)	$ (615,892)	$ (21,292)	$ (628,892)
BASIC AND DILUTED LOSS PER SHARE OF COMMON STOCK	$ (0.01)	$ (0.55)	$ (0.02)	$ (0.57)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	1,111,460	1,111,460	1,111,460	1,111,460

XML 15 R4.htm IDEA: XBRL DOCUMENT

Statements of Cash Flows - USD ($)	9 Months Ended
Statements of Cash Flows - USD ($)	Sep. 30, 2016	Sep. 30, 2015
OPERATING ACTIVITIES
Profit (loss)	$ (21,292)	$ (628,892)
Adjustments to reconcile net loss to cash flows from operating activities
Services contributed by an officer	4,500	4,500
Expenses paid on behalf of the Company	116,404
Change in loss on settlement of debt		605,437
Changes in operating assets and liabilities
Accounts payable	(68,776)	5,847
Accounts payable - related parties	(30,798)	(2,380)
Net Cash Provided by (Used in) Operating Activities	38	(15,488)
FINANCING ACTIVITIES
Proceeds from notes payable - related parties		15,150
NET CHANGE IN CASH	38	(338)
CASH AT BEGINNING OF PERIOD	7	502
CASH AT END OF PERIOD	$ 45	$ 164
NON-CASH FINANCING ACTIVITIES:
Common shares issued for rounding pursuant to reverse stock-split		110
Common stock issued for Settlement of debt		650,000

XML 16 R5.htm IDEA: XBRL DOCUMENT

Note 1 - Condensed Financial Statements

9 Months Ended

Sep. 30, 2016

Notes

Note 1 - Condensed Financial Statements

NOTE 1 - CONDENSED FINANCIAL STATEMENTS

XML 17 R6.htm IDEA: XBRL DOCUMENT

Note 2 - Going Concern

9 Months Ended

Sep. 30, 2016

Notes

Note 2 - Going Concern

NOTE 2 - GOING CONCERN

XML 18 R7.htm IDEA: XBRL DOCUMENT

Note 3 - Significant Accounting Policies

9 Months Ended

Sep. 30, 2016

Notes

Note 3 - Significant Accounting Policies

NOTE 3 – SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

Basic (Loss) per Common Share

Recent Accounting Pronouncements

XML 19 R8.htm IDEA: XBRL DOCUMENT

Note 4 - Related-party Transactions

9 Months Ended

Sep. 30, 2016

Notes

Note 4 - Related-party Transactions

NOTE 4 – RELATED-PARTY TRANSACTIONS

Contributed Capital

During the nine months ended September 30, 2016 and 2015, a related-party has contributed various administrative services to the Company. These services have been valued at $3,000 for the nine month periods then ended.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References + Details

XML 20 R9.htm IDEA: XBRL DOCUMENT

Note 5 - Stockholders' Equity

9 Months Ended

Sep. 30, 2016

Notes

Note 5 - Stockholders' Equity

NOTE 5 – STOCKHOLDERS’ EQUITY

On September 19, 2014, the Company issued 26,000 shares of common stock to Blue Cap Development Corp. in exchange for certain mining and/or mineral claims and/or leases located in New Mexico. Two principals of Blue Cap, Edward F. Cowle and H. Deworth Williams, are principal stockholders of the Company.

On November 4, 2014, the Company effected a reverse stock split of its issued and outstanding shares of common stock on a one (1) share for one thousand (1,000) shares basis. As per the terms of the reverse stock split, any fractional share amount resulting from the split was automatically rounded up to the next higher whole share amount, with the provision that no individual stockholder’s holdings would be reduced below 100 shares. Additional shares to restore each such affected stockholder’s holdings to 100 shares were issued, with certain shares issued during the 2014 calendar year, and the remainder issued during the nine months ended September 30, 2015. The par value of the common stock remains at $0.005 per share. As a result of the reverse stock split and the rounding up of odd lots to 100 shares, at September 30, 2015, there were 1,111,460 shares certificated and outstanding.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Note 6 - Subsequent Events

9 Months Ended

Sep. 30, 2016

Notes

Note 6 - Subsequent Events

NOTE 6 – SUBSEQUENT EVENTS

In accordance with ASC 855-10, Company management reviewed all material events through the date of this report and determined that there are no additional material subsequent events to report.

XML 22 R11.htm IDEA: XBRL DOCUMENT

Note 3 - Significant Accounting Policies: Use of Estimates (Policies)

9 Months Ended

Sep. 30, 2016

Policies

Use of Estimates

XML 23 R12.htm IDEA: XBRL DOCUMENT

Note 3 - Significant Accounting Policies: Basic (loss) Per Common Share (Policies)

9 Months Ended

Sep. 30, 2016

Policies

Basic (loss) Per Common Share

Basic (Loss) per Common Share

XML 24 R13.htm IDEA: XBRL DOCUMENT

Note 3 - Significant Accounting Policies: Recent Accounting Pronouncements (Policies)

9 Months Ended

Sep. 30, 2016

Policies

Recent Accounting Pronouncements

XML 25 R14.htm IDEA: XBRL DOCUMENT

Note 4 - Related-party Transactions: Contributed Capital (Policies)

9 Months Ended

Sep. 30, 2016

Policies

Contributed Capital

EXCEL 26 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 27 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 28 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 30 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 9 58 1 false 0 0 false 3 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://prtt/20160930/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 000020 - Statement - Balance Sheets Sheet http://prtt/20160930/role/idr_BalanceSheets Balance Sheets Statements 2 false false R3.htm 000030 - Statement - Statements of Operations Sheet http://prtt/20160930/role/idr_StatementsOfOperations Statements of Operations Statements 3 false false R4.htm 000040 - Statement - Statements of Cash Flows Sheet http://prtt/20160930/role/idr_StatementsOfCashFlows Statements of Cash Flows Statements 4 false false R5.htm 000050 - Disclosure - Note 1 - Condensed Financial Statements Sheet http://prtt/20160930/role/idr_DisclosureNote1CondensedFinancialStatements Note 1 - Condensed Financial Statements Notes 5 false false R6.htm 000060 - Disclosure - Note 2 - Going Concern Sheet http://prtt/20160930/role/idr_DisclosureNote2GoingConcern Note 2 - Going Concern Notes 6 false false R7.htm 000070 - Disclosure - Note 3 - Significant Accounting Policies Sheet http://prtt/20160930/role/idr_DisclosureNote3SignificantAccountingPolicies Note 3 - Significant Accounting Policies Notes 7 false false R8.htm 000080 - Disclosure - Note 4 - Related-party Transactions Sheet http://prtt/20160930/role/idr_DisclosureNote4RelatedPartyTransactions Note 4 - Related-party Transactions Notes 8 false false R9.htm 000090 - Disclosure - Note 5 - Stockholders' Equity Sheet http://prtt/20160930/role/idr_DisclosureNote5StockholdersEquity Note 5 - Stockholders' Equity Notes 9 false false R10.htm 000100 - Disclosure - Note 6 - Subsequent Events Sheet http://prtt/20160930/role/idr_DisclosureNote6SubsequentEvents Note 6 - Subsequent Events Notes 10 false false R11.htm 000110 - Disclosure - Note 3 - Significant Accounting Policies: Use of Estimates (Policies) Sheet http://prtt/20160930/role/idr_DisclosureNote3SignificantAccountingPoliciesUseOfEstimatesPolicies Note 3 - Significant Accounting Policies: Use of Estimates (Policies) Policies http://prtt/20160930/role/idr_DisclosureNote3SignificantAccountingPolicies 11 false false R12.htm 000120 - Disclosure - Note 3 - Significant Accounting Policies: Basic (loss) Per Common Share (Policies) Sheet http://prtt/20160930/role/idr_DisclosureNote3SignificantAccountingPoliciesBasicLossPerCommonSharePolicies Note 3 - Significant Accounting Policies: Basic (loss) Per Common Share (Policies) Policies http://prtt/20160930/role/idr_DisclosureNote3SignificantAccountingPolicies 12 false false R13.htm 000130 - Disclosure - Note 3 - Significant Accounting Policies: Recent Accounting Pronouncements (Policies) Sheet http://prtt/20160930/role/idr_DisclosureNote3SignificantAccountingPoliciesRecentAccountingPronouncementsPolicies Note 3 - Significant Accounting Policies: Recent Accounting Pronouncements (Policies) Policies http://prtt/20160930/role/idr_DisclosureNote3SignificantAccountingPolicies 13 false false R14.htm 000140 - Disclosure - Note 4 - Related-party Transactions: Contributed Capital (Policies) Sheet http://prtt/20160930/role/idr_DisclosureNote4RelatedPartyTransactionsContributedCapitalPolicies Note 4 - Related-party Transactions: Contributed Capital (Policies) Policies http://prtt/20160930/role/idr_DisclosureNote3SignificantAccountingPolicies 14 false false All Reports Book All Reports prtt-20160930.xml prtt-20160930.xsd prtt-20160930_cal.xml prtt-20160930_def.xml prtt-20160930_lab.xml prtt-20160930_pre.xml true true ZIP 32 0001551163-16-000549-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001551163-16-000549-xbrl.zip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